AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A budget calculator informs decisions by translating income and expenses into actionable insights. Learn how to apply results to smarter financial moves.
19,403 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Civilians in the Black Sea peninsula face fuel shortages as russia-occupied crimea halts gas sales amid intensified U...
When the market hears that the federal reserve just delivered a hawkish message, a storm of headlines follows. This g...
As July 2 approaches, investors debate whether to buy Tesla stock ahead of the Q2 delivery data. This guide breaks do...
As SpaceX captures headlines, a quieter but powerful growth wave is building in quantum computing. This guide highlig...
Federal regulators weigh possible actions after new allegations that polymarket allegedly faked trades. The case test...
As rates likely rise this year, stocks face a new environment. This guide breaks down what that means for the S&P 500...
President Trump launches a Department of Justice probe into gasoline pricing after asserting that consumers are being...
Two budding EV stars, Lucid and Rivian, are racing from zero to scale. This deep dive compares their paths, risks, an...
The Justice Department announced a multi-state PFAS settlement with Chemours, totaling about $450 million in penaltie...
Glenn Kelman has joined Greylock Partners as an executive in residence, months after stepping down from Redfin and fo...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...